CORRECTION FROM SOURCE: cbdMD, Inc. to Host Conference Call to Discuss March 31, 2022, Second Quarter Results
This release corrects and replaces the previous release editing the date of the Quarter Ending March 30 to March 31,...
This release corrects and replaces the previous release editing the date of the Quarter Ending March 30 to March 31,...
Charlotte, North Carolina--(Newsfile Corp. - May 6, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
VANCOUVER, BC / ACCESSWIRE / May 6, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it...
Artificial intelligence (AI) and healthcare access remain key themes at ISMRM as researchers and clinicians seek more efficient and effective...
Accomplished Industry Leader Honored by the Orange County Business Journal ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider...
DURHAM, N.C., May 06, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it...
IRVINE, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / May 6, 2022 / Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration...
GENEVA, SWITZERLAND / ACCESSWIRE / May 6, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTY) ("Relief" or the "Company"), a biopharmaceutical...
Authorities can rely on a robust decision-making tool to strengthen their fight against the COVID-19 pandemic and future health risks....
PHOENIX, May 5, 2022 /PRNewswire/ -- Digital mental health company, Bezyl, Inc. is collaborating with Ukrainian-based developer, Sigma Software for a...
Congress contains no possibilities for extension or exceptions to the MMJ CULTIVATION application determination deadline in accordance with section 304(c)..."...